We are live on ! Find out more
HAE icon

Haemonetics

181 hedge funds and large institutions have $2.22B invested in Haemonetics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 79 increasing their positions, 54 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $9K | Put options by funds: $3K

46% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 54

5% more capital invested

Capital invested by funds: $2.11B → $2.22B (+$108M)

3.54% more ownership

Funds ownership: 101.53%105.07% (+3.5%)

8% less funds holding

Funds holding: 197181 (-16)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

Holders
181
Holders Change
-16
Holders Change %
-8.12%
% of All Funds
4.51%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
15
Increased
79
Reduced
54
Closed
24
Calls
$9K
Puts
$3K
Net Calls
+$6K
Net Calls Change
+$492K
Name Holding Trade Value Shares
Change
Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$4.31M +$1.01M +25,945 +32%
New York State Teachers Retirement System (NYSTRS)
52
New York State Teachers Retirement System (NYSTRS)
New York
$4.11M
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$4.09M -$184K -4,700 -4%
Prudential Financial
54
Prudential Financial
New Jersey
$4.07M -$121K -3,090 -3%
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$3.96M -$285K -7,300 -7%
HHC
56
Hutchin Hill Capital
New York
$3.81M +$1.93M +49,500 +111%
Legal & General Group
57
Legal & General Group
United Kingdom
$3.71M +$28.6K +733 +0.8%
TA
58
Teachers Advisors
New York
$3.63M +$169K +4,337 +5%
RCAMU
59
Rothschild & Co Asset Management US
Connecticut
$3.55M -$143K -3,656 -4%
Swiss National Bank
60
Swiss National Bank
Switzerland
$3.47M +$46.9K +1,200 +1%
Two Sigma Advisers
61
Two Sigma Advisers
New York
$3.34M +$1.27M +32,500 +65%
AllianceBernstein
62
AllianceBernstein
Tennessee
$3.3M -$430 -11 -0%
Morgan Stanley
63
Morgan Stanley
New York
$3.27M -$3.22M -82,484 -51%
CS
64
Credit Suisse
Switzerland
$3.02M -$271K -6,939 -9%
Canada Life
65
Canada Life
Manitoba, Canada
$2.99M +$195K +4,986 +7%
BNP Paribas Asset Management
66
BNP Paribas Asset Management
France
$2.9M
FC
67
Fairpointe Capital
Illinois
$2.9M
ACM
68
ADI Capital Management
New York
$2.88M +$2.77M +70,966 New
Comerica Bank
69
Comerica Bank
Texas
$2.87M +$514K +13,151 +24%
PCM
70
Piermont Capital Management
Missouri
$2.85M -$273K -7,000 -9%
JP Morgan Chase
71
JP Morgan Chase
New York
$2.57M -$3.04M -77,842 -55%
Acadian Asset Management
72
Acadian Asset Management
Massachusetts
$2.5M -$254K -6,515 -10%
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$2.42M +$14K +359 +0.6%
Bessemer Group
74
Bessemer Group
New Jersey
$2.34M
CIM
75
Confluence Investment Management
Missouri
$2.23M -$23.2K -594 -1%

HAE Hedge Fund Activity: Q1 2017 in Review

181 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2017, worth a combined $2.22B — up 5.1% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of HAE and 15 opened new positions — a net loss of 9 holders — while 54 trimmed existing stakes and 79 added.

The largest buyer was BlackRock, adding an estimated $245M. The largest seller was T. Rowe Price Associates, cutting an estimated $75.4M.

  • 181 institutional investors held Haemonetics (HAE) as of Q1 2017, down from 197 in Q4 2016.
  • Funds reported $2.22B of Haemonetics stock for Q1 2017, up 5.1% quarter-over-quarter.
  • 15 funds opened new Haemonetics positions in Q1 2017 and 24 closed out, a net change of -9 holders.
  • The largest Haemonetics buyer in Q1 2017 was BlackRock, an estimated $245M added.
  • The largest Haemonetics seller in Q1 2017 was T. Rowe Price Associates, an estimated $75.4M sold.

Based on aggregated 13F filings for Q1 2017.